Update: The US-backed hepatitis B vaccine trial in African newborns in Guinea-Bissau, which drew global backlash, "will not move forward," according to the Guardian. The Guardian
the GuardianControversial US-backed vaccine trial in African newborns haltedHepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’